Astronics Corp: Form 10-Q for the period ended Sep 30, 2023
Filed with the SEC on Nov 9, 2023 and accepted by EDGAR at Nov 9, 2023, 19:39 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-07-02 to 2023-09-30 | $162.9m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2023-01-01 to 2023-09-30 | $493.9m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-07-02 to 2023-09-30 | $142.3m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2023-01-01 to 2023-09-30 | $413.1m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2023-07-02 to 2023-09-30 | $20.6m | us-gaap:GrossProfit |
| Gross profit | 9 months2023-01-01 to 2023-09-30 | $80.8m | us-gaap:GrossProfit |
| Research and development | 3 months2023-07-02 to 2023-09-30 | $14.1m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2023-01-01 to 2023-09-30 | $39.5m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2023-07-02 to 2023-09-30 | $35.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2023-01-01 to 2023-09-30 | $95.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-07-02 to 2023-09-30 | −$14.5m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2023-01-01 to 2023-09-30 | −$14.5m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2023-07-02 to 2023-09-30 | −$3.8m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2023-01-01 to 2023-09-30 | $5.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-07-02 to 2023-09-30 | −$17.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months2023-01-01 to 2023-09-30 | −$33.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-07-02 to 2023-09-30 | −$0.51 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2023-01-01 to 2023-09-30 | −$1.02 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-07-02 to 2023-09-30 | −$0.51 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2023-01-01 to 2023-09-30 | −$1.02 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-07-02 to 2023-09-30 | 33,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2023-01-01 to 2023-09-30 | 32,707,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2023-01-01 to 2023-09-30 | −$22.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2023-01-01 to 2023-09-30 | $6.0m | us-gaap:PaymentsToAcquireProductiveAssets |
| Cash and equivalents | At period end2023-09-30 | $4.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-09-30 | $381.2m | us-gaap:AssetsCurrent |
| Total assets | At period end2023-09-30 | $630.9m | us-gaap:Assets |
| Current liabilities | At period end2023-09-30 | $158.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-09-30 | $398.5m | us-gaap:Liabilities |
| Long-term debt | At period end2023-09-30 | $160.0m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2023-09-30 | $9.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2023-09-30 | $232.4m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000008063-23-000059. Last ingested by Listed: Oct 24, 2026, 14:51 ET. Listed shows no prices and gives no investment advice.